Hi-Great Group Holding (HIGR) EBITDA (2019 - 2026)
Hi-Great Group Holding's (HIGR) quarterly EBITDA came in at -$7205.0 in Q1 2026, up 42.29% year-over-year from -$5063.6 in Q1 2025, and up 83.22% quarter-over-quarter from -$42940.0 in Q4 2025.
Analysis
Hi-Great Group Holding (HIGR) EBITDA (2019 - 2026) Analysis & Trends
Hi-Great Group Holding has disclosed EBITDA across 8 years of filings, most recently posting -$7205.0 for Q1 2026.
- In Q1 2026, EBITDA rose 42.29% year-over-year to -$7205.0; the TTM figure through Mar 2026 stood at -$75474.0 (down 101.79% YoY), while the FY2025 annual figure was -$80754.0, down 180.05% from the prior year.
- EBITDA came in at -$7205.0 for Q1 2026 at Hi-Great Group Holding, up from -$42940.0 in the prior quarter.
- In the past five years, EBITDA ranged from a high of $107709.0 in Q4 2022 to a low of -$58600.0 in Q2 2023.
- Average EBITDA over 5 years is -$6712.0, with a median of -$11366.0 recorded in 2022.
- Year-over-year, EBITDA jumped 289.43% in 2022 and slumped 665.42% in 2025.
- Over 5 years, EBITDA stood at $107709.0 in 2022, then tumbled by 122.21% to -$23927.0 in 2023, then surged by 76.55% to -$5610.0 in 2024, then tumbled by 665.42% to -$42940.0 in 2025, then surged by 83.22% to -$7205.0 in 2026.
- Per Business Quant data, the three most recent EBITDA figures were -$7205.0 in Q1 2026, -$42940.0 in Q4 2025, and -$8286.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 1.02 Bn |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 699.00 Mn |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 633.00 Mn |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | 216.00 Mn |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 23.50 Mn |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | 128.30 Mn |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | 25.00 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Hi-Great Group Holding | 1.02 Mn | 1.02 Mn | 5,981.00 | -7,205.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -7,205.00 |
| Dec 31, 2025 | -42,940.00 |
| Sep 30, 2025 | -8,286.00 |
| Jun 30, 2025 | -17,043.00 |
| Mar 31, 2025 | -12,485.00 |
| Dec 31, 2024 | -5,610.00 |
| Sep 30, 2024 | -6,836.00 |
| Jun 30, 2024 | -12,472.00 |
| Mar 31, 2024 | -3,918.00 |
| Dec 31, 2023 | -23,927.00 |
| Sep 30, 2023 | -24,838.00 |
| Jun 30, 2023 | -58,600.00 |
| Mar 31, 2023 | 21,882.00 |
| Dec 31, 2022 | 107,709.00 |
| Sep 30, 2022 | -11,366.00 |
| Jun 30, 2022 | -37,412.00 |
| Mar 31, 2022 | 29,243.00 |
| Dec 31, 2021 | -56,860.00 |
| Sep 30, 2021 | 44,242.00 |
| Jun 30, 2021 | 29,146.00 |